vs

Side-by-side financial comparison of ASSEMBLY BIOSCIENCES, INC. (ASMB) and Idaho Strategic Resources, Inc. (IDR). Click either name above to swap in a different company.

Idaho Strategic Resources, Inc. is the larger business by last-quarter revenue ($14.6M vs $10.8M, roughly 1.4× ASSEMBLY BIOSCIENCES, INC.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -85.2%, a 149.5% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs 57.6%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $-15.2M).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.

ASMB vs IDR — Head-to-Head

Bigger by revenue
IDR
IDR
1.4× larger
IDR
$14.6M
$10.8M
ASMB
Growing faster (revenue YoY)
IDR
IDR
+34.4% gap
IDR
92.0%
57.6%
ASMB
Higher net margin
IDR
IDR
149.5% more per $
IDR
64.3%
-85.2%
ASMB
More free cash flow
IDR
IDR
$23.3M more FCF
IDR
$8.2M
$-15.2M
ASMB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASMB
ASMB
IDR
IDR
Revenue
$10.8M
$14.6M
Net Profit
$-9.2M
$9.4M
Gross Margin
68.5%
Operating Margin
-100.9%
62.4%
Net Margin
-85.2%
64.3%
Revenue YoY
57.6%
92.0%
Net Profit YoY
4.3%
220.6%
EPS (diluted)
$-0.72
$0.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASMB
ASMB
IDR
IDR
Q4 25
$14.6M
Q3 25
$10.8M
$11.1M
Q2 25
$9.6M
$9.5M
Q1 25
$9.4M
$7.3M
Q4 24
$7.4M
$7.6M
Q3 24
$6.8M
$6.2M
Q2 24
$8.5M
$6.1M
Q1 24
$5.8M
$5.9M
Net Profit
ASMB
ASMB
IDR
IDR
Q4 25
$9.4M
Q3 25
$-9.2M
$3.0M
Q2 25
$-10.2M
$2.8M
Q1 25
$-8.8M
$1.6M
Q4 24
$2.9M
Q3 24
$-9.6M
$1.6M
Q2 24
$-11.2M
$2.2M
Q1 24
$-9.1M
$2.2M
Gross Margin
ASMB
ASMB
IDR
IDR
Q4 25
68.5%
Q3 25
63.6%
Q2 25
57.8%
Q1 25
50.8%
Q4 24
53.3%
Q3 24
48.7%
Q2 24
50.2%
Q1 24
48.1%
Operating Margin
ASMB
ASMB
IDR
IDR
Q4 25
62.4%
Q3 25
-100.9%
23.4%
Q2 25
-115.2%
26.6%
Q1 25
-105.5%
19.3%
Q4 24
36.2%
Q3 24
-160.1%
23.4%
Q2 24
-143.0%
34.2%
Q1 24
-185.5%
36.3%
Net Margin
ASMB
ASMB
IDR
IDR
Q4 25
64.3%
Q3 25
-85.2%
26.8%
Q2 25
-105.9%
29.2%
Q1 25
-93.6%
22.1%
Q4 24
38.5%
Q3 24
-140.4%
25.8%
Q2 24
-130.7%
35.2%
Q1 24
-156.9%
36.8%
EPS (diluted)
ASMB
ASMB
IDR
IDR
Q4 25
$0.62
Q3 25
$-0.72
$0.20
Q2 25
$-1.33
$0.20
Q1 25
$-1.17
$0.12
Q4 24
$0.21
Q3 24
$-1.51
$0.12
Q2 24
$-1.98
$0.17
Q1 24
$-1.66
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASMB
ASMB
IDR
IDR
Cash + ST InvestmentsLiquidity on hand
$22.5M
Total DebtLower is stronger
$2.3M
Stockholders' EquityBook value
$182.7M
$108.2M
Total Assets
$240.0M
$116.2M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASMB
ASMB
IDR
IDR
Q4 25
Q3 25
$22.5M
Q2 25
$24.0M
Q1 25
$23.4M
Q4 24
$38.3M
Q3 24
$28.5M
Q2 24
$19.2M
$6.3M
Q1 24
$18.7M
$5.3M
Total Debt
ASMB
ASMB
IDR
IDR
Q4 25
$2.3M
Q3 25
$3.0M
Q2 25
$3.3M
Q1 25
$3.7M
Q4 24
$1.7M
Q3 24
$2.9M
Q2 24
$2.7M
Q1 24
$3.3M
Stockholders' Equity
ASMB
ASMB
IDR
IDR
Q4 25
$108.2M
Q3 25
$182.7M
$74.3M
Q2 25
$18.1M
$49.3M
Q1 25
$27.1M
$39.8M
Q4 24
$33.4M
$37.7M
Q3 24
$26.0M
$33.1M
Q2 24
$34.7M
$25.4M
Q1 24
$32.6M
$21.6M
Total Assets
ASMB
ASMB
IDR
IDR
Q4 25
$116.2M
Q3 25
$240.0M
$83.1M
Q2 25
$80.8M
$57.7M
Q1 25
$99.0M
$48.1M
Q4 24
$119.2M
$44.0M
Q3 24
$100.3M
$40.8M
Q2 24
$115.3M
$32.2M
Q1 24
$119.9M
$28.7M
Debt / Equity
ASMB
ASMB
IDR
IDR
Q4 25
0.02×
Q3 25
0.04×
Q2 25
0.07×
Q1 25
0.09×
Q4 24
0.05×
Q3 24
0.09×
Q2 24
0.11×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASMB
ASMB
IDR
IDR
Operating Cash FlowLast quarter
$-15.1M
$10.7M
Free Cash FlowOCF − Capex
$-15.2M
$8.2M
FCF MarginFCF / Revenue
-140.7%
56.0%
Capex IntensityCapex / Revenue
0.4%
17.7%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$12.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASMB
ASMB
IDR
IDR
Q4 25
$10.7M
Q3 25
$-15.1M
$2.4M
Q2 25
$-16.8M
$3.5M
Q1 25
$-23.4M
$2.4M
Q4 24
$-51.1M
$3.2M
Q3 24
$-15.2M
$2.5M
Q2 24
$-17.1M
$2.6M
Q1 24
$-18.4M
$2.6M
Free Cash Flow
ASMB
ASMB
IDR
IDR
Q4 25
$8.2M
Q3 25
$-15.2M
$709.8K
Q2 25
$2.5M
Q1 25
$1.0M
Q4 24
$-51.1M
$2.1M
Q3 24
$1.9M
Q2 24
$-17.1M
$2.4M
Q1 24
$-18.4M
$2.3M
FCF Margin
ASMB
ASMB
IDR
IDR
Q4 25
56.0%
Q3 25
-140.7%
6.4%
Q2 25
26.5%
Q1 25
13.8%
Q4 24
-695.2%
28.0%
Q3 24
30.4%
Q2 24
-200.6%
38.7%
Q1 24
-317.7%
38.3%
Capex Intensity
ASMB
ASMB
IDR
IDR
Q4 25
17.7%
Q3 25
0.4%
15.3%
Q2 25
0.0%
10.8%
Q1 25
0.0%
19.4%
Q4 24
0.4%
13.6%
Q3 24
0.0%
9.8%
Q2 24
0.2%
4.3%
Q1 24
0.2%
5.5%
Cash Conversion
ASMB
ASMB
IDR
IDR
Q4 25
1.15×
Q3 25
0.81×
Q2 25
1.28×
Q1 25
1.50×
Q4 24
1.08×
Q3 24
1.56×
Q2 24
1.22×
Q1 24
1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons